| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 1.92e-10 | 11 | 19 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.07e-08 | 32 | 19 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 6.40e-08 | 42 | 19 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 6.16e-06 | 130 | 19 | 4 | GO:0005200 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 6.22e-04 | 39 | 19 | 2 | GO:0031369 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 1.06e-03 | 51 | 19 | 2 | GO:0003743 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.10e-03 | 873 | 19 | 5 | GO:0019901 | |
| GeneOntologyMolecularFunction | kinase binding | 1.75e-03 | 969 | 19 | 5 | GO:0019900 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 2.92e-03 | 85 | 19 | 2 | GO:0008135 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 5.01e-03 | 112 | 19 | 2 | GO:0090079 | |
| GeneOntologyMolecularFunction | ribosome binding | 5.73e-03 | 120 | 19 | 2 | GO:0043022 | |
| GeneOntologyMolecularFunction | structural molecule activity | 8.92e-03 | 891 | 19 | 4 | GO:0005198 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.59e-08 | 31 | 19 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 2.64e-08 | 35 | 19 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | formation of cytoplasmic translation initiation complex | 8.38e-05 | 15 | 19 | 2 | GO:0001732 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.68e-04 | 313 | 19 | 4 | GO:0099173 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 6.51e-04 | 803 | 19 | 5 | GO:0030036 | |
| GeneOntologyBiologicalProcess | cytoplasmic translational initiation | 7.77e-04 | 45 | 19 | 2 | GO:0002183 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 1.16e-03 | 912 | 19 | 5 | GO:0030029 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.55e-03 | 974 | 19 | 5 | GO:0034330 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.57e-03 | 566 | 19 | 4 | GO:0007409 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.72e-08 | 32 | 19 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.72e-08 | 32 | 19 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 7.09e-08 | 45 | 19 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.41e-06 | 94 | 19 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.12e-06 | 104 | 19 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.55e-06 | 109 | 19 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | actin filament | 8.16e-06 | 146 | 19 | 4 | GO:0005884 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 2.81e-05 | 9 | 19 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex | 9.32e-05 | 16 | 19 | 2 | GO:0005852 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 1.19e-04 | 18 | 19 | 2 | GO:0033290 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.32e-04 | 576 | 19 | 5 | GO:0015629 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 1.33e-04 | 19 | 19 | 2 | GO:0016282 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 1.47e-04 | 20 | 19 | 2 | GO:0070993 | |
| GeneOntologyCellularComponent | transferase complex | 1.39e-03 | 963 | 19 | 5 | GO:1990234 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | 1.45e-03 | 972 | 19 | 5 | GO:0140535 | |
| GeneOntologyCellularComponent | supramolecular fiber | 3.39e-03 | 1179 | 19 | 5 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 3.49e-03 | 1187 | 19 | 5 | GO:0099081 | |
| GeneOntologyCellularComponent | blood microparticle | 7.46e-03 | 144 | 19 | 2 | GO:0072562 | |
| GeneOntologyCellularComponent | axon | 7.61e-03 | 891 | 19 | 4 | GO:0030424 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 7.85e-03 | 899 | 19 | 4 | GO:0099513 | |
| MousePheno | abnormal hallux morphology | 4.60e-06 | 5 | 10 | 2 | MP:0009049 | |
| MousePheno | head spot | 2.07e-05 | 10 | 10 | 2 | MP:0002939 | |
| MousePheno | belly spot | 3.72e-04 | 41 | 10 | 2 | MP:0000373 | |
| MousePheno | white spotting | 5.54e-04 | 50 | 10 | 2 | MP:0002938 | |
| Domain | ANK | 5.42e-13 | 251 | 18 | 9 | SM00248 | |
| Domain | ANK_REPEAT | 5.82e-13 | 253 | 18 | 9 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 6.04e-13 | 254 | 18 | 9 | IPR020683 | |
| Domain | ANK_REP_REGION | 6.04e-13 | 254 | 18 | 9 | PS50297 | |
| Domain | Ankyrin_rpt | 7.99e-13 | 262 | 18 | 9 | IPR002110 | |
| Domain | Ank_2 | 1.07e-11 | 215 | 18 | 8 | PF12796 | |
| Domain | Ank | 1.72e-11 | 228 | 18 | 8 | PF00023 | |
| Domain | - | 3.37e-11 | 248 | 18 | 8 | 1.25.40.20 | |
| Domain | Actin_CS | 1.09e-09 | 16 | 18 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 1.43e-09 | 17 | 18 | 4 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.83e-09 | 18 | 18 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.32e-09 | 19 | 18 | 4 | PS01132 | |
| Domain | ACTIN | 1.87e-08 | 31 | 18 | 4 | SM00268 | |
| Domain | Actin | 1.87e-08 | 31 | 18 | 4 | IPR004000 | |
| Domain | Actin | 1.87e-08 | 31 | 18 | 4 | PF00022 | |
| Domain | EIF3C_N_dom | 8.77e-07 | 2 | 18 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 8.77e-07 | 2 | 18 | 2 | PF05470 | |
| Domain | EIF3C | 8.77e-07 | 2 | 18 | 2 | IPR027516 | |
| Domain | PINT | 1.04e-04 | 16 | 18 | 2 | SM00088 | |
| Domain | PCI | 1.18e-04 | 17 | 18 | 2 | PF01399 | |
| Domain | PCI_dom | 1.18e-04 | 17 | 18 | 2 | IPR000717 | |
| Domain | - | 1.83e-02 | 218 | 18 | 2 | 1.10.10.10 | |
| Pathway | WP_TRANSLATION_FACTORS | 1.91e-04 | 51 | 6 | 2 | MM15881 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | 3.10e-04 | 65 | 6 | 2 | MM15416 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_INITIATION | 1.11e-03 | 123 | 6 | 2 | MM15415 | |
| Pathway | REACTOME_TRANSLATION | 3.84e-03 | 231 | 6 | 2 | MM15420 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.40e-02 | 450 | 6 | 2 | M27078 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 5.51e-17 | 15 | 19 | 6 | 16824795 | |
| Pubmed | 7.74e-17 | 163 | 19 | 9 | 24316575 | ||
| Pubmed | 1.65e-16 | 6 | 19 | 5 | 17171436 | ||
| Pubmed | 2.22e-12 | 7 | 19 | 4 | 15276201 | ||
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 12475935 | ||
| Pubmed | 8.00e-12 | 9 | 19 | 4 | 16364570 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 1.38e-10 | 3 | 19 | 3 | 17101985 | |
| Pubmed | 5.53e-10 | 4 | 19 | 3 | 17342726 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.28e-09 | 271 | 19 | 6 | 32433965 | |
| Pubmed | 2.05e-07 | 96 | 19 | 4 | 23580065 | ||
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 2.83e-07 | 2 | 19 | 2 | 36157221 | |
| Pubmed | Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. | 2.83e-07 | 2 | 19 | 2 | 18447647 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.83e-07 | 2 | 19 | 2 | 19669888 | |
| Pubmed | 1.19e-06 | 149 | 19 | 4 | 22664934 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 10504338 | ||
| Pubmed | 1.02e-05 | 9 | 19 | 2 | 24003236 | ||
| Pubmed | 1.02e-05 | 9 | 19 | 2 | 21292980 | ||
| Pubmed | 1.27e-05 | 10 | 19 | 2 | 16286006 | ||
| Pubmed | Conservation and diversity of eukaryotic translation initiation factor eIF3. | 1.27e-05 | 10 | 19 | 2 | 8995409 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.62e-05 | 288 | 19 | 4 | 31501420 | |
| Pubmed | 1.85e-05 | 95 | 19 | 3 | 33863777 | ||
| Pubmed | Reconstitution reveals the functional core of mammalian eIF3. | 1.86e-05 | 12 | 19 | 2 | 17581632 | |
| Pubmed | 1.86e-05 | 12 | 19 | 2 | 14519125 | ||
| Pubmed | 2.56e-05 | 14 | 19 | 2 | 18599441 | ||
| Pubmed | 2.96e-05 | 15 | 19 | 2 | 17322308 | ||
| Pubmed | 3.83e-05 | 17 | 19 | 2 | 34752747 | ||
| Pubmed | 6.49e-05 | 22 | 19 | 2 | 25331947 | ||
| Pubmed | Genetic loci influencing natural variations in femoral bone morphometry in mice. | 9.84e-05 | 27 | 19 | 2 | 11518254 | |
| Pubmed | Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. | 1.76e-04 | 36 | 19 | 2 | 16097034 | |
| Pubmed | 3.13e-04 | 1153 | 19 | 5 | 29845934 | ||
| Pubmed | 3.55e-04 | 51 | 19 | 2 | 16919471 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 4.75e-04 | 59 | 19 | 2 | 16083285 | |
| Interaction | ACTG2 interactions | 9.20e-08 | 49 | 18 | 4 | int:ACTG2 | |
| Interaction | POTEG interactions | 1.31e-07 | 12 | 18 | 3 | int:POTEG | |
| Interaction | POTEH interactions | 7.53e-07 | 2 | 18 | 2 | int:POTEH | |
| Interaction | POTEJ interactions | 1.29e-05 | 52 | 18 | 3 | int:POTEJ | |
| Interaction | CAP2 interactions | 2.64e-05 | 66 | 18 | 3 | int:CAP2 | |
| Interaction | ATPSCKMT interactions | 4.12e-05 | 11 | 18 | 2 | int:ATPSCKMT | |
| Interaction | ADARB1 interactions | 5.44e-05 | 489 | 18 | 5 | int:ADARB1 | |
| Interaction | POTEC interactions | 5.84e-05 | 13 | 18 | 2 | int:POTEC | |
| Interaction | PFDN2 interactions | 5.89e-05 | 247 | 18 | 4 | int:PFDN2 | |
| Interaction | ADAR interactions | 1.04e-04 | 286 | 18 | 4 | int:ADAR | |
| Interaction | POTEI interactions | 1.06e-04 | 105 | 18 | 3 | int:POTEI | |
| Interaction | ACTBL2 interactions | 1.19e-04 | 296 | 18 | 4 | int:ACTBL2 | |
| Interaction | POTEE interactions | 2.18e-04 | 134 | 18 | 3 | int:POTEE | |
| Interaction | ACTA2 interactions | 2.38e-04 | 355 | 18 | 4 | int:ACTA2 | |
| Interaction | NDUFA4L2 interactions | 2.61e-04 | 27 | 18 | 2 | int:NDUFA4L2 | |
| Interaction | ACTA1 interactions | 2.82e-04 | 371 | 18 | 4 | int:ACTA1 | |
| Interaction | POTEB3 interactions | 4.41e-04 | 35 | 18 | 2 | int:POTEB3 | |
| Interaction | OCRL interactions | 4.85e-04 | 176 | 18 | 3 | int:OCRL | |
| Interaction | TFCP2 interactions | 5.20e-04 | 436 | 18 | 4 | int:TFCP2 | |
| Interaction | RPS6KA2 interactions | 6.64e-04 | 196 | 18 | 3 | int:RPS6KA2 | |
| Interaction | MEPCE interactions | 7.49e-04 | 859 | 18 | 5 | int:MEPCE | |
| Cytoband | 2q21.1 | 8.76e-09 | 58 | 19 | 4 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 4.19e-07 | 151 | 19 | 4 | chr2q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q21 | 1.14e-03 | 121 | 19 | 2 | chr6q21 | |
| Cytoband | 15q11.2 | 2.29e-03 | 172 | 19 | 2 | 15q11.2 | |
| Cytoband | 14q11.2 | 2.50e-03 | 180 | 19 | 2 | 14q11.2 | |
| Cytoband | 16p11.2 | 2.81e-03 | 191 | 19 | 2 | 16p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q11 | 3.61e-03 | 217 | 19 | 2 | chr15q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 8.22e-03 | 332 | 19 | 2 | chr14q11 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 2.52e-27 | 13 | 14 | 9 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 2.24e-14 | 242 | 14 | 9 | 403 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 9.64e-11 | 584 | 19 | 9 | MM1080 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | 3.55e-08 | 282 | 19 | 6 | MM3642 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 5.29e-07 | 92 | 19 | 4 | MM503 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | 6.38e-05 | 309 | 19 | 4 | MM1244 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 2.44e-04 | 32 | 19 | 2 | MM1307 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.58e-13 | 63 | 19 | 6 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.44e-12 | 90 | 19 | 6 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-07 | 136 | 19 | 4 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.99e-07 | 136 | 19 | 4 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.16e-07 | 180 | 19 | 4 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.16e-07 | 180 | 19 | 4 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.74e-06 | 65 | 19 | 3 | 3592efe68696dd5b806183c8bcd4957c1cd8e045 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.74e-06 | 65 | 19 | 3 | c53b6e1e454b7c34cac07b287ffd9e8e64fa79c8 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Endometrioid_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.62e-06 | 95 | 19 | 3 | 48ad5d89ee9a1941d1d3dbdbfb03893a390c0d64 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Endometrioid_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.90e-06 | 96 | 19 | 3 | 4cca2f5e754b82075740adaa0a147d16368be908 | |
| ToppCell | TCGA-Prostate|World / Sample_Type by Project: Shred V9 | 1.87e-05 | 123 | 19 | 3 | 22b38555652b7a426a6277ed385361ae275310a3 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-05 | 175 | 19 | 3 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-05 | 197 | 19 | 3 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| Disease | Disease Exacerbation | 1.65e-03 | 165 | 11 | 2 | C0235874 | |
| Disease | JT interval | 3.68e-03 | 248 | 11 | 2 | EFO_0007885 | |
| Disease | cognitive function measurement, self reported educational attainment | 7.39e-03 | 355 | 11 | 2 | EFO_0004784, EFO_0008354 | |
| Disease | electrocardiography | 1.59e-02 | 530 | 11 | 2 | EFO_0004327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WECTKMKFGTSHMMV | 1501 | Q96N23 | |
| MDSSACKKSHQSKKW | 1 | Q8N5N4 | |
| DSFMKTLRSKMGKWC | 51 | H3BUK9 | |
| DSAMKTLRSKMGKWC | 51 | A5A3E0 | |
| SALWGMKSVFDMKHS | 1161 | Q9Y4B6 | |
| DSAMKTLRSKMGKWC | 51 | Q6S8J3 | |
| VKFSCMAWTHDGKGM | 171 | P48147 | |
| HVVAASKAMKMGDWK | 736 | Q99613 | |
| SKAMKMGDWKTCHSF | 741 | Q99613 | |
| ASKAMKMGDWKTCHS | 741 | B5ME19 | |
| KCNKTHSFMHWKMRS | 216 | P26951 | |
| WRKKFSFMCKMSASA | 56 | Q5T8I3 | |
| GVMQKTCSMKVHWGT | 1151 | Q9Y4K1 | |
| HWMAACRLASKGKTM | 466 | Q96AC1 | |
| DSFMKTLRSKMGKWC | 51 | A0A0A6YYL3 | |
| DSTMKTLRSKMGKWC | 51 | P0CG39 | |
| DSTMKTLRSKMGKWC | 51 | P0CG38 | |
| KISAASKMMWCSAAV | 36 | Q5GFL6 | |
| DSAMKTLRSKMGKWC | 51 | Q6S5H5 | |
| DSAMKTLRSKMGKWC | 51 | Q6S545 | |
| SAMKTLRSKMGKWCC | 126 | Q6S545 | |
| DSAMKTLRSKMGKWC | 51 | A6NI47 |